Calidi Biotherapeutics (CLDI) Amortizatization of Intangibles (2022 - 2024)
Calidi Biotherapeutics (CLDI) posted quarterly Amortizatization of Intangibles of $4000.0 for Q4 2024, up 101.43% year-over-year from $1985.8 in Q1 2024, and down 55.56% quarter-over-quarter from $9000.0 in Q3 2024.
Calidi Biotherapeutics (CLDI) Amortizatization of Intangibles (2022 - 2024) Analysis & Trends
Calidi Biotherapeutics' Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at $4000.0 for Q4 2024.
- In Q4 2024, Amortizatization of Intangibles rose 101.43% year-over-year to $4000.0; the TTM figure through Dec 2024 stood at $45000.0 (down 67.75% YoY), while the FY2024 annual figure was $45000.0, down 89.58% from the prior year.
- Amortizatization of Intangibles for Q4 2024 stood at $4000.0, down from $9000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $201000.0 in Q1 2023, with the low at -$279000.0 in Q4 2023.
- The 3-year median for Amortizatization of Intangibles is $16000.0 (2024), against an average of $33724.8.
- The sharpest annual moves came in 2023 and 2024: Amortizatization of Intangibles tumbled 334.45% in 2023, then soared 101.43% in 2024.
- Calidi Biotherapeutics' Amortizatization of Intangibles stood at $119000.0 in 2022, then tumbled by 334.45% to -$279000.0 in 2023, then soared by 101.43% to $4000.0 in 2024.
- Business Quant data shows CLDI's Amortizatization of Intangibles at $4000.0 in Q4 2024, $9000.0 in Q3 2024, and $16000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Calidi Biotherapeutics | 1.88 Mn | -2.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 4,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 16,000.00 |
| Jun 30, 2024 | 16,000.00 |
| Mar 31, 2024 | 16,000.00 |
| Mar 31, 2024 | 16,000.00 |
| Dec 31, 2023 | -279,000.00 |
| Dec 31, 2023 | -279,000.00 |
| Sep 30, 2023 | 201,000.00 |
| Sep 30, 2023 | 201,000.00 |
| Jun 30, 2023 | 16,523.00 |
| Jun 30, 2023 | 16,523.00 |
| Mar 31, 2023 | 201,000.00 |
| Mar 31, 2023 | 201,000.00 |
| Dec 31, 2022 | 119,000.00 |
| Dec 31, 2022 | 119,000.00 |